1. 1560 Quality of life (QoL) evaluation in head and neck cancer (HNC) patients: Electronics beats paper. (September 2015) Authors: Van Oevelen, K.; Vanderveken, O.; Dewaele, E.; Verschueren, C.; Mariën, S.; Van Laer, C.; Wouters, K.; Van Fraeyenhove, B.; Specenier, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2817 12-year Follow-up (FU) Data and late local toxicity Of Two Cohorts of patients with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) treated with Concomitant Chemoradiation (CCRT) With Or Without Induction Chemotherapy (ICT). (September 2015) Authors: Dewaele, E.; Vermorken, J.; Verschueren, C.; Vanderveken, O.; Van Laer, C.; Mariën, S.; Specenier, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2822 Gemcitabine-based chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: A literature review and meta-analysis. (September 2015) Authors: Szturz, P.; Vanderveken, O.M.; Specenier, P.; Merlano, M.C.; Benasso, M.; Van Gestel, D.; Wouters, K.; Van Laer, C.; Weyngaert, D. Van Den; Peeters, M.; Vermorken, J.B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Concurrent chemoradiation (CCRT) or radiotherapy with anti-EGFR directed monoclonal antibody (anti-EGFR) or CCRT + anti-EGFR in locoregionally advanced head-and-neck squamous cell carcinoma (LA-HNSCC): a comprehensive review of randomized data. (February 2017) Authors: Specenier, P.; Janssens, K.; Vermorken, J.B. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Premedication for prophylaxis of hypersensitivity reactions (HSR) after weekly or 3-weekly paclitaxel (ptx): a comprehensive literature review. (February 2017) Authors: Dewaele, E.; Specenier, P. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor. Issue 4 (3rd May 2016) Authors: Van den Bossche, J.; Lardon, F.; Deschoolmeester, V.; De Pauw, I.; Vermorken, J.B.; Specenier, P.; Pauwels, P.; Peeters, M.; Wouters, A. Journal: Medicinal research reviews Issue: Volume 36:Issue 4(2016:Jul.) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The prognostic value of the comprehensive geriatric assessment (CGA) in elderly cancer patients (ECP) treated with chemotherapy (CT): a systematic review. (February 2017) Authors: Janssens, K.; Specenier, P. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗